OTCMKTS:SQZB SQZ Biotechnologies (SQZB) Stock Price, News & Analysis → A new way to collect income from stocks (From DTI) (Ad) Free SQZB Stock Alerts $0.05 0.00 (0.00%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$0.05▼$0.0550-Day Range$0.04▼$0.0552-Week Range$0.01▼$0.69VolumeN/AAverage Volume30,409 shsMarket Capitalization$1.37 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartEarningsFinancialsSEC FilingsShort InterestStock AnalysisAnalyst ForecastsChartEarningsFinancialsSEC FilingsShort Interest Get SQZ Biotechnologies alerts: Email Address Ad DTIIf you have $2,500 bucks… check this out This computer whiz has been averaging 234% per year with an undefeated strategy he calls… The “Income Glitch” And he’s been making out like a bandit with a 100% success rate on over 64 trade opportunities! Click here to unlock the Income Glitch training workshop for free. About SQZ BiotechnologiesSQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination with immuno-oncology agents for the treatment of HPV16+ advanced or metastatic solid tumors, including cervical, head-and-neck, anal, penile, vulvar, and vaginal cancer. The company also develops SQZ-AAC-HPV, which is in a Phase I clinical trial for the treatment of HPV16+ advanced or metastatic solid tumors in monotherapy and in combinations with immune-oncology agents. Its additional platforms in development are SQZ Activating Antigen Carriers; and SQZ Tolerizing Antigen Carriers. The Company was incorporated in 2013 and is headquartered in Watertown, Massachusetts.Read More SQZB Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SQZB Stock News HeadlinesFebruary 29, 2024 | businesswire.comSTEMCELL Technologies Announces Successful Asset Purchase Agreement with SQZ Biotechnologies CompanyFebruary 29, 2024 | businesswire.comAsset Sale and Plan of Liquidation and Dissolution Approved by SQZB ShareholdersApril 27, 2024 | True Market Insiders (Ad)Exposed: 10 CENT Crypto to Explode April 20th?The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…December 12, 2023 | businesswire.comIntroducing Portal BiotechnologiesSee More Headlines Receive SQZB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for SQZ Biotechnologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/27/2024Next Earnings (Estimated)5/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biological products, except diagnostic Sub-IndustryN/A Current SymbolOTCMKTS:SQZB CUSIPN/A CIK1604477 Webwww.sqzbiotech.com Phone617-758-8672FaxN/AEmployees53Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($2.43) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-79,460,000.00 Net MarginsN/A Pretax Margin-591.07% Return on Equity-206.79% Return on Assets-99.55% Debt Debt-to-Equity RatioN/A Current Ratio1.37 Quick Ratio1.37 Sales & Book Value Annual Sales$21.48 million Price / Sales0.06 Cash FlowN/A Price / Cash FlowN/A Book Value$1.94 per share Price / Book0.02Miscellaneous Outstanding Shares29,490,000Free Float24,772,000Market Cap$1.37 million OptionableN/A Beta1.51 Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesDr. Howard Bernstein M.D. (Age 67)Ph.D., Interim CEO & Director Comp: $552.14kMr. Lawrence J. Knopf Esq. (Age 62)General Counsel & Secretary Comp: $512.38kDr. Marshelle Smith Warren M.D. (Age 60)Chief Medical Officer Comp: $476.27kDr. Robert S. Langer Jr. (Age 75)Ph.D., Co-Founder & Member of Scientific Advisory Board Mr. Richard V. Capasso CPA (Age 62)Chief Accounting Officer Mr. David First (Age 60)Chief People Officer Ipsita Roymoulik Ph.D.Senior Vice President of CMC & QUALITYMore ExecutivesKey CompetitorsSQZ BiotechnologiesNYSE:SQZWindtree TherapeuticsNASDAQ:WINTTC BiopharmNASDAQ:TCBPScinai ImmunotherapeuticsNASDAQ:SCNIAcorda TherapeuticsNASDAQ:ACORView All Competitors SQZB Stock Analysis - Frequently Asked Questions Should I buy or sell SQZ Biotechnologies stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for SQZ Biotechnologies in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" SQZB shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SQZB, but not buy additional shares or sell existing shares. View SQZB analyst ratings or view top-rated stocks. How have SQZB shares performed in 2024? SQZ Biotechnologies' stock was trading at $0.0199 at the beginning of 2024. Since then, SQZB shares have increased by 133.7% and is now trading at $0.0465. View the best growth stocks for 2024 here. Are investors shorting SQZ Biotechnologies? SQZ Biotechnologies saw a decrease in short interest in the month of March. As of March 31st, there was short interest totaling 27,700 shares, a decrease of 38.4% from the March 15th total of 45,000 shares. Based on an average daily volume of 177,000 shares, the days-to-cover ratio is currently 0.2 days. View SQZ Biotechnologies' Short Interest. When is SQZ Biotechnologies' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024. View our SQZB earnings forecast. How do I buy shares of SQZ Biotechnologies? Shares of SQZB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:SQZB) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyProtect Your Bank Account Before It’s Too LateWeiss RatingsHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe World's First "$20 Trillion Drug?"Behind the MarketsBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SQZ Biotechnologies Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
